Precision oncology without borders. For the next billion patients.

Scroll
01 — PROBLEM

Weeks to get results. Thousands per test. Built on data that doesn't represent most of the world.

2–6.

Weeks · median wait

for actionable molecular results

$3–6k.

Per test

comprehensive genomic profiling cost

85–90%.

GWAS participants

of European ancestry

78.4%.

US ONCOLOGY TRIALS ENROLLED

of European ancestry


02 — SOLUTION

Decentralized Multi-modal Ancestry-aware cancer diagnostics.

We bridge the gap in healthcare access by meeting clinicians and patients at the point of need, using reference data that reflects their genetic backgrounds.

Faster.

Results in days, not weeks or months. Decentralized hardware operates in community hospitals and clinics, eliminating the need to ship samples and wait for answers.

Cheaper.

A fraction of today's per-test cost. AI inference on the edge replaces the economics of centralized labs, unlocking comprehensive profiling for the patients who need it most.

Smarter.

Our models combine multimodal functional biomarkers, pangenome references, and advanced classification algorithms to interpret variants across ancestries that legacy systems misread or overlook. Data-sovereignty by design.


03 — WHO WE ARE

Built by Silicon Valley genomics R&D leaders from Agilent and NVIDIA.

From San Juan, Puerto Rico to the Americas and beyond.


04 — OUR MARK
Omiquity Diffraction Spots Mark — twelve circles arranged in three decreasing sizes along two crossing diagonal arms

Derived from Photo 51, the X-ray diffraction image captured by Raymond Gosling under Rosalind Franklin's supervision in 1952, which revealed the structure of DNA.

Twelve solid circles arranged along two crossing diagonal arms in three decreasing sizes, abstracting the diffraction spot pattern where energy dissipates outward from a central source. The diamond-shaped void at the center represents the absence that proved DNA's bases face inward: a discovery made visible by what was missing.

Our mark carries that principle. Genomic diversity is not a gap. It's the map.

Trusted by Institutional partners
Parallel18
Puerto Rico Science, Technology, and Research Trust
Puerto Rico Consortium for Clinical Investigation
UPR Comprehensive Cancer Center
PanOncology Research Foundation
Ponce Health Sciences University

05 — REGISTER FOR UPDATES

See the full picture.

If you are a clinician, researcher, investor, or potential partner, register to follow our progress and get early access when we launch.

This field is required

This field is required

This field is required

Please enter a valid email

Received

Thank you for your interest. We'll keep you updated on our progress and notify you when full platform access is available.